1. Home
  2. ICD-10-CM MS-DRG V41.0
  3. Diagnosis Codes in MS-DRG 948 - SIGNS AND SYMPTOMS WITHOUT MCC

Diagnosis Codes in MS-DRG 948 - SIGNS AND SYMPTOMS WITHOUT MCC

The Medicare Severity Diagnosis-Related Group or MS-DRG is a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). This is the group for Diagnosis Codes in MS-DRG 948 - SIGNS AND SYMPTOMS WITHOUT Major Complication or Comorbidity diseases in version MS-DRG V41.0 applicable from 10/01/2023 through 09/30/2024.

MS-DRG MS-DRG Title MCD Relative Weight Geometric LOS Arithmetic LOS
948 SIGNS AND SYMPTOMS WITHOUT MCC 23 0.8010 Relative Weight
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.		 0.80 Geometric Length of Stay
The geometric mean length of stay (GMLOS) is used by Medicare to calculate the reimbursement for patients whose medical treatment takes a much longer or shorter time than average.		 2.60 Arithmetic Length of Stay
The average length of stay (ALOS) reflects the average number of days a patient spends in a hospital for each admission.

List of ICD-10-CM Codes in Diagnostic Related Group


  • E07.8
    • E07.81 Sick-euthyroid syndrome
  • E79
    • E79.0 Hyperuricemia without signs of inflammatory arthritis and tophaceous disease
  • G89.1
    • G89.11 Acute pain due to trauma
    • G89.12 Acute post-thoracotomy pain
    • G89.18 Other acute postprocedural pain
  • G89
    • G89.3 Neoplasm related pain (acute) (chronic)
  • G93.3
    • G93.31 Postviral fatigue syndrome
    • G93.32 Myalgic encephalomyelitis/chronic fatigue syndrome
    • G93.39 Other post infection and related fatigue syndromes
  • P09
    • P09.1 Abnormal findings on neonatal screening for inborn errors of metabolism
    • P09.2 Abnormal findings on neonatal screening for congenital endocrine disease
    • P09.3 Abnormal findings on neonatal screening for congenital hematologic disorders
    • P09.4 Abnormal findings on neonatal screening for cystic fibrosis
    • P09.5 Abnormal findings on neonatal screening for critical congenital heart disease
    • P09.6 Abnormal findings on neonatal screening for neonatal hearing loss
    • P09.8 Other abnormal findings on neonatal screening
    • P09.9 Abnormal findings on neonatal screening, unspecified
  • R18
  • R23
  • R41
    • R41.0 Disorientation, unspecified
    • R41.1 Anterograde amnesia
    • R41.2 Retrograde amnesia
    • R41.3 Other amnesia
    • R41.9 Unspecified symptoms and signs involving cognitive functions and awareness
  • R41.8
    • R41.82 Altered mental status, unspecified
  • R45.8
    • R45.83 Excessive crying of child, adolescent or adult
    • R45.84 Anhedonia
    • R52 Pain, unspecified
    • R64 Cachexia
  • R53
    • R53.0 Neoplastic (malignant) related fatigue
    • R53.1 Weakness
    • R53.2 Functional quadriplegia
  • R53.8
  • R60
  • R68
    • R68.0 Hypothermia, not associated with low environmental temperature
  • R68.1
    • R68.11 Excessive crying of infant (baby)
    • R68.12 Fussy infant (baby)
  • R68.8
    • R68.81 Early satiety
    • R68.83 Chills (without fever)
    • R68.89 Other general symptoms and signs
  • R70
    • R70.0 Elevated erythrocyte sedimentation rate
    • R70.1 Abnormal plasma viscosity
  • R74.0
    • R74.01 Elevation of levels of liver transaminase levels
    • R74.02 Elevation of levels of lactic acid dehydrogenase [LDH]
  • R74
    • R74.8 Abnormal levels of other serum enzymes
    • R74.9 Abnormal serum enzyme level, unspecified
  • R77
    • R77.0 Abnormality of albumin
    • R77.1 Abnormality of globulin
    • R77.2 Abnormality of alphafetoprotein
    • R77.8 Other specified abnormalities of plasma proteins
    • R77.9 Abnormality of plasma protein, unspecified
  • R78
    • R78.1 Finding of opiate drug in blood
    • R78.2 Finding of cocaine in blood
    • R78.3 Finding of hallucinogen in blood
    • R78.4 Finding of other drugs of addictive potential in blood
    • R78.5 Finding of other psychotropic drug in blood
    • R78.6 Finding of steroid agent in blood
    • R78.9 Finding of unspecified substance, not normally found in blood
  • R78.7
    • R78.71 Abnormal lead level in blood
    • R78.79 Finding of abnormal level of heavy metals in blood
  • R78.8
    • R78.89 Finding of other specified substances, not normally found in blood
  • R79
    • R79.0 Abnormal level of blood mineral
    • R79.1 Abnormal coagulation profile
    • R79.9 Abnormal finding of blood chemistry, unspecified
  • R79.8
    • R79.81 Abnormal blood-gas level
    • R79.82 Elevated C-reactive protein (CRP)
    • R79.83 Abnormal findings of blood amino-acid level
    • R79.89 Other specified abnormal findings of blood chemistry
  • R82
  • R84
    • R84.0 Abnormal level of enzymes in specimens from respiratory organs and thorax
    • R84.1 Abnormal level of hormones in specimens from respiratory organs and thorax
    • R84.2 Abnormal level of other drugs, medicaments and biological substances in specimens from respiratory organs and thorax
    • R84.3 Abnormal level of substances chiefly nonmedicinal as to source in specimens from respiratory organs and thorax
    • R84.4 Abnormal immunological findings in specimens from respiratory organs and thorax
    • R84.5 Abnormal microbiological findings in specimens from respiratory organs and thorax
    • R84.6 Abnormal cytological findings in specimens from respiratory organs and thorax
    • R84.7 Abnormal histological findings in specimens from respiratory organs and thorax
    • R84.8 Other abnormal findings in specimens from respiratory organs and thorax
    • R84.9 Unspecified abnormal finding in specimens from respiratory organs and thorax
  • R85
    • R85.0 Abnormal level of enzymes in specimens from digestive organs and abdominal cavity
    • R85.1 Abnormal level of hormones in specimens from digestive organs and abdominal cavity
    • R85.2 Abnormal level of other drugs, medicaments and biological substances in specimens from digestive organs and abdominal cavity
    • R85.3 Abnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity
    • R85.4 Abnormal immunological findings in specimens from digestive organs and abdominal cavity
    • R85.5 Abnormal microbiological findings in specimens from digestive organs and abdominal cavity
    • R85.7 Abnormal histological findings in specimens from digestive organs and abdominal cavity
    • R85.9 Unspecified abnormal finding in specimens from digestive organs and abdominal cavity
  • R85.6
    • R85.69 Abnormal cytological findings in specimens from other digestive organs and abdominal cavity
  • R85.8
    • R85.89 Other abnormal findings in specimens from digestive organs and abdominal cavity
  • R87
    • R87.0 Abnormal level of enzymes in specimens from female genital organs
    • R87.1 Abnormal level of hormones in specimens from female genital organs
    • R87.2 Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs
    • R87.3 Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs
    • R87.4 Abnormal immunological findings in specimens from female genital organs
    • R87.5 Abnormal microbiological findings in specimens from female genital organs
    • R87.7 Abnormal histological findings in specimens from female genital organs
    • R87.9 Unspecified abnormal finding in specimens from female genital organs
  • R87.6
    • R87.69 Abnormal cytological findings in specimens from other female genital organs
  • R87.8
    • R87.89 Other abnormal findings in specimens from female genital organs
  • R88
    • R88.0 Cloudy (hemodialysis) (peritoneal) dialysis effluent
    • R88.8 Abnormal findings in other body fluids and substances
  • R89
    • R89.0 Abnormal level of enzymes in specimens from other organs, systems and tissues
    • R89.1 Abnormal level of hormones in specimens from other organs, systems and tissues
    • R89.2 Abnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues
    • R89.3 Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues
    • R89.4 Abnormal immunological findings in specimens from other organs, systems and tissues
    • R89.5 Abnormal microbiological findings in specimens from other organs, systems and tissues
    • R89.6 Abnormal cytological findings in specimens from other organs, systems and tissues
    • R89.8 Other abnormal findings in specimens from other organs, systems and tissues
  • R90.8
    • R90.89 Other abnormal findings on diagnostic imaging of central nervous system
  • R93.8
    • R93.89 Abnormal findings on diagnostic imaging of other specified body structures
  • R93
    • R93.9 Diagnostic imaging inconclusive due to excess body fat of patient
  • R97
    • R97.0 Elevated carcinoembryonic antigen [CEA]
    • R97.1 Elevated cancer antigen 125 [CA 125]
    • R97.8 Other abnormal tumor markers
  • R97.2
    • R97.20 Elevated prostate specific antigen [PSA]
    • R97.21 Rising PSA following treatment for malignant neoplasm of prostate